var data={"title":"Calcium carbonate: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Calcium carbonate: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/5788?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=calcium-carbonate-patient-drug-information\" class=\"drug drug_patient\">see &quot;Calcium carbonate: Patient drug information&quot;</a> and <a href=\"topic.htm?path=calcium-carbonate-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Calcium carbonate: Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144392\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Alcalak [OTC] [DSC];</li>\n      <li>Antacid Calcium Extra Strength [OTC];</li>\n      <li>Antacid Calcium [OTC];</li>\n      <li>Antacid Extra Strength [OTC];</li>\n      <li>Antacid [OTC];</li>\n      <li>Cal-Carb Forte [OTC];</li>\n      <li>Cal-Gest Antacid [OTC];</li>\n      <li>Cal-Mint [OTC];</li>\n      <li>Calcarb 600 [OTC] [DSC];</li>\n      <li>Calci-Chew [OTC];</li>\n      <li>Calci-Mix [OTC] [DSC];</li>\n      <li>Calcium 600 [OTC];</li>\n      <li>Calcium Antacid Extra Strength [OTC];</li>\n      <li>Calcium Antacid Ultra Max St [OTC];</li>\n      <li>Calcium Antacid [OTC];</li>\n      <li>Calcium High Potency [OTC];</li>\n      <li>Caltrate 600 [OTC];</li>\n      <li>Florical [OTC];</li>\n      <li>Maalox Childrens [OTC];</li>\n      <li>Maalox [OTC];</li>\n      <li>Oysco 500 [OTC];</li>\n      <li>Titralac [OTC];</li>\n      <li>Tums Chewy Bites [OTC];</li>\n      <li>Tums Chewy Delights [OTC];</li>\n      <li>Tums E-X 750 [OTC];</li>\n      <li>Tums Extra Strength 750 [OTC];</li>\n      <li>Tums Freshers [OTC];</li>\n      <li>Tums Kids [OTC];</li>\n      <li>Tums Lasting Effects [OTC];</li>\n      <li>Tums Smoothies [OTC];</li>\n      <li>Tums Ultra 1000 [OTC];</li>\n      <li>Tums [OTC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144393\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Apo-Cal;</li>\n      <li>Calcite-500;</li>\n      <li>Caltrate;</li>\n      <li>Caltrate Select;</li>\n      <li>Os-Cal;</li>\n      <li>Tums Chews Extra Strength;</li>\n      <li>Tums Extra Strength;</li>\n      <li>Tums Regular Strength;</li>\n      <li>Tums Smoothies;</li>\n      <li>Tums Ultra Strength</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144430\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Antacid;</li>\n      <li>\n        Antidote;</li>\n      <li>\n        Calcium Salt;</li>\n      <li>\n        Electrolyte Supplement, Oral;</li>\n      <li>\n        Phosphate Binder</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144397\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Note: </b>One gram of calcium carbonate is equal to 400 mg of elemental calcium.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dosage is in terms of calcium <b>carbonate</b> except where noted; calcium carbonate generally provides approximately 40% elemental calcium:</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">\n      <b>Calcium supplementation:</b> Oral: 500 mg to 4 g daily in 1 to 3 divided doses</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Antacid:</b> Oral: Generally, 1 to 4 tablets as symptoms occur; maximum: 8,000 mg daily for up to 2 weeks; OTC dosing recommendations may vary by product and/or manufacturer; specific product labeling should be consulted</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Hyperphosphatemia in chronic kidney disease (off-label use):</b> Total dose of elemental calcium (including dietary sources and calcium-based phosphate binders) should not exceed 2000 mg daily (Eknoyan 2003).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144415\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=calcium-carbonate-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Calcium carbonate: Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Note: </b>One gram of calcium carbonate is equal to 400 mg of elemental calcium.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dosage is in terms of calcium <b>carbonate</b>, except where noted; calcium carbonate generally provides approximately 40% elemental calcium:</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">\n      <b>Antacid:</b> Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children 2 to 5 years (10.9 to 21.3 kg): 375 to 400 mg as symptoms occur; maximum: 1,500 mg daily for up to 2 weeks; OTC dosing recommendations may vary by product and/or manufacturer; specific product labeling should be consulted.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children 6 to11 years (&ge;21.8 kg): 750 to 800 mg as symptoms occur; maximum: 3,000 mg daily for up to 2 weeks; OTC dosing recommendations may vary by product and/or manufacturer; specific product labeling should be consulted.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children &ge;12 years and Adolescents: 500 to 3,000 mg as symptoms occur for up to 2 weeks; maximum daily dose: 7,500 mg/day; OTC dosing recommendations may vary by product and/or manufacturer; specific product labeling should be consulted.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Calcium supplementation:</b> Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children 2 to 4 years: 750 mg twice daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children &ge;4 years and Adolescents: 750 mg 3 times daily</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144398\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144399\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">CrCl &lt;25 mL/minute: Dosage adjustments may be necessary depending on the serum calcium levels.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24764257\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling (has not been studied).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45703130\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Capsule, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calci-Mix: 1250 mg (elemental calcium 500 mg) [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Florical: 364 mg (elemental calcium 145 mg) and fluoride 3.75 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Powder, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: Elemental calcium 800 mg/2 g (480 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Suspension, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1250 mg (elemental calcium 500 mg) per 5 mL (5 mL, 473 mL, 500 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cal-Carb Forte: 1250 mg (elemental calcium 500 mg)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcarb 600: 1500 mg (elemental calcium 600 mg) [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium 600: 1500 mg (elemental calcium 600 mg) [scored]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium 600: 1500 mg (elemental calcium 600 mg) [contains fd&amp;c yellow #6 aluminum lake, soy polysaccarides]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium High Potency: 1500 mg (elemental calcium 600 mg)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Caltrate 600: 1500 mg (elemental calcium 600 mg) [scored]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Florical: 364 mg (elemental calcium 145 mg) and fluoride 3.75 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Oysco 500: 1250 mg (elemental calcium 500 mg) [contains brilliant blue fcf (fd&amp;c blue #1), tartrazine (fd&amp;c yellow #5)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 648 mg, 1250 mg (elemental calcium 500 mg), 1500 mg (elemental calcium 600 mg)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium 600: 1500 mg (elemental calcium 600 mg) [lactose free, salt free, sugar free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1250 mg (elemental calcium 500 mg), 1500 mg (elemental calcium 600 mg)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet Chewable, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Alcalak: 420 mg [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Antacid: 420 mg [DSC], 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Antacid: 500 mg [peppermint flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Antacid: 500 mg [contains brilliant blue fcf (fd&amp;c blue #1), fd&amp;c yellow #10 (quinoline yellow), fd&amp;c yellow #6 (sunset yellow)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Antacid: 500 mg [contains fd&amp;c blue #1 aluminum lake, fd&amp;c red #40 aluminum lake, fd&amp;c yellow #5 aluminum lake, fd&amp;c yellow #6 aluminum lake]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Antacid Calcium: 500 mg [peppermint flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Antacid Calcium: 500 mg [gluten free; peppermint flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Antacid Calcium Extra Strength: 750 mg [DSC] [contains fd&amp;c blue #1 aluminum lake, fd&amp;c red #40 aluminum lake; assorted flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Antacid Calcium Extra Strength: 750 mg [gluten free; contains fd&amp;c blue #1 aluminum lake, fd&amp;c red #40 aluminum lake; assorted fruit flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Antacid Extra Strength: 750 mg [contains brilliant blue fcf (fd&amp;c blue #1), fd&amp;c red #40]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Antacid Extra Strength: 750 mg [contains fd&amp;c red #40, fd&amp;c yellow #6 (sunset yellow), tartrazine (fd&amp;c yellow #5)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cal-Gest Antacid: 500 mg [DSC] [contains fd&amp;c blue #1 aluminum lake, fd&amp;c yellow #10 aluminum lake, fd&amp;c yellow #6 aluminum lake]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cal-Gest Antacid: 500 mg [contains fd&amp;c blue #1 aluminum lake, fd&amp;c yellow #10 aluminum lake, fd&amp;c yellow #6 aluminum lake; assorted fruit flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cal-Mint: Elemental calcium 260 mg [animal products free, gelatin free, gluten free, lactose free, no artificial color(s), no artificial flavor(s), starch free, sugar free, yeast free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calci-Chew: 1250 mg (elemental calcium 500 mg) [cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium Antacid: 500 mg [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium Antacid: 500 mg [contains brilliant blue fcf (fd&amp;c blue #1), fd&amp;c red #40, fd&amp;c yellow #10 (quinoline yellow), fd&amp;c yellow #6 (sunset yellow)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium Antacid: 500 mg [contains brilliant blue fcf (fd&amp;c blue #1), fd&amp;c red #40, fd&amp;c yellow #6 (sunset yellow), soybeans (glycine max), tartrazine (fd&amp;c yellow #5); assorted flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium Antacid: 500 mg [contains fd&amp;c blue #1 aluminum lake]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium Antacid: 500 mg [contains fd&amp;c blue #1 aluminum lake, fd&amp;c yellow #10 aluminum lake, fd&amp;c yellow #6 aluminum lake; assorted fruit flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium Antacid Extra Strength: 750 mg [DSC] [assorted fruit flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium Antacid Extra Strength: 750 mg [contains brilliant blue fcf (fd&amp;c blue #1), fd&amp;c red #40]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium Antacid Extra Strength: 750 mg [contains brilliant blue fcf (fd&amp;c blue #1), fd&amp;c red #40, fd&amp;c yellow #6 (sunset yellow), tartrazine (fd&amp;c yellow #5); assorted flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium Antacid Extra Strength: 750 mg [DSC] [contains fd&amp;c blue #1 aluminum lake, fd&amp;c red #40 aluminum lake]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium Antacid Extra Strength: 750 mg [gluten free; contains brilliant blue fcf (fd&amp;c blue #1), fd&amp;c yellow #10 (quinoline yellow), fd&amp;c yellow #6 (sunset yellow)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium Antacid Ultra Max St: 1000 mg [contains brilliant blue fcf (fd&amp;c blue #1), fd&amp;c red #40, fd&amp;c yellow #6 (sunset yellow), soybeans (glycine max), tartrazine (fd&amp;c yellow #5)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Maalox: 600 mg [contains aspartame; wild berry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Maalox Childrens: 400 mg [contains aspartame; wild berry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Titralac: 420 mg [low sodium, sugar free; contains saccharin]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums: 500 mg [peppermint flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums: 500 mg [gluten free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums: 500 mg [gluten free; contains fd&amp;c blue #1 aluminum lake, fd&amp;c red #40 aluminum lake, fd&amp;c yellow #6 aluminum lake, tartrazine (fd&amp;c yellow #5)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Chewy Bites: 750 mg [contains corn starch, fd&amp;c blue #1 aluminum lake, fd&amp;c blue #2 aluminum lake, fd&amp;c red #40 aluminum lake, fd&amp;c yellow #5 aluminum lake, fd&amp;c yellow #6 aluminum lake, methylparaben, propylparaben, sodium benzoate, soybean lecithin, soybean oil]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Chewy Delights: 1177 mg [contains coconut oil (copra/cocos nucifera oil), corn starch, fd&amp;c yellow #6 (sunset yellow), soybean lecithin]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Chewy Delights: 1177 mg [contains fd&amp;c red #40 aluminum lake, soybean lecithin; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums E-X 750: 750 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums E-X 750: 750 mg [assorted flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums E-X 750: 750 mg [gluten free; contains fd&amp;c blue #1 aluminum lake, fd&amp;c red #40 aluminum lake; assorted berries flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums E-X 750: 750 mg [sugar free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Extra Strength 750: 750 mg [gluten free; contains fd&amp;c blue #1 aluminum lake, fd&amp;c red #40 aluminum lake, fd&amp;c yellow #5 aluminum lake, fd&amp;c yellow #6 aluminum lake; assorted fruit flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Extra Strength 750: 750 mg [sugar free; contains fd&amp;c red #40 aluminum lake, fd&amp;c yellow #5 aluminum lake]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Freshers: 500 mg [gluten free; contains brilliant blue fcf (fd&amp;c blue #1); mint flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Freshers: 500 mg [kosher certified; contains brilliant blue fcf (fd&amp;c blue #1), tartrazine (fd&amp;c yellow #5); spearmint flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Kids: 750 mg [scored; contains fd&amp;c blue #1 aluminum lake, fd&amp;c red #40 aluminum lake; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Lasting Effects: 500 mg [contains fd&amp;c red #40 aluminum lake, fd&amp;c yellow #6 aluminum lake, tartrazine (fd&amp;c yellow #5)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Smoothies: 750 mg [peppermint flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Smoothies: 750 mg [contains fd&amp;c blue #1 aluminum lake, fd&amp;c red #40 aluminum lake, fd&amp;c yellow #6 aluminum lake, soybeans (glycine max); assorted tropical fruit flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Smoothies: 750 mg [contains fd&amp;c blue #1 aluminum lake, fd&amp;c red #40 aluminum lake, soybeans (glycine max); berry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Smoothies: 750 mg [gluten free; contains corn starch, fd&amp;c blue #1 aluminum lake, fd&amp;c red #40 aluminum lake, fd&amp;c yellow #5 aluminum lake, fd&amp;c yellow #6 aluminum lake, soybeans (glycine max)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Ultra 1000: 1000 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Ultra 1000: 1000 mg [peppermint flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Ultra 1000: 1000 mg [contains fd&amp;c blue #1 aluminum lake, fd&amp;c red #40 aluminum lake, fd&amp;c yellow #5 aluminum lake, fd&amp;c yellow #6 aluminum lake; assorted berries flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Ultra 1000: 1000 mg [contains fd&amp;c red #40 aluminum lake, fd&amp;c yellow #6 aluminum lake, tartrazine (fd&amp;c yellow #5); assorted tropical fruit flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tums Ultra 1000: 1000 mg [gluten free; contains fd&amp;c blue #1 aluminum lake, fd&amp;c red #40 aluminum lake, fd&amp;c yellow #6 aluminum lake, tartrazine (fd&amp;c yellow #5)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 500 mg, 750 mg, Elemental calcium 260 mg</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144362\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F21879436\" class=\"block dosfc drugH1Div\"><span class=\"drugH1\">Dosage Forms Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">1 g calcium carbonate = elemental calcium 400 mg = calcium 20 mEq = calcium 10 mmol</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24764258\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Oral: Administer with food.  </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Capsules may be swallowed whole or opened and the contents mixed with food or drink.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144378\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Antacid:</b> For the relief of acid indigestion, heartburn, sour stomach, and GI upset associated with these symptoms</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Calcium supplementation:</b> For use as a dietary supplement when calcium intake may be inadequate (eg, osteoporosis, osteomalacia, hypocalcemic rickets) (IOM, 2011)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25475274\" class=\"block off-label drugH1Div\"><span class=\"drugH1\">Use: Off-Label</span>\n    <p>Hyperphosphatemia in chronic kidney disease</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144437\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Calcium carbonate may be confused with calcitriol</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Children&rsquo;s Pepto may be confused with Pepto-Bismol products</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Maalox and Children&rsquo;s Maalox may be confused with other Maalox products</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Mylanta may be confused with Mynatal </p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Os-Cal [DSC] may be confused with Asacol</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">International issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Remegel [Hungary, Great Britain, and Ireland] may be confused with Renagel brand name for sevelamer [US, Canada, and multiple international markets]</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Remegel: Brand name for calcium carbonate [Hungary, Great Britain, and Ireland], but also the brand name for aluminum hydroxide and magnesium carbonate [Netherlands]</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144369\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Well tolerated </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">1% to 10%: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Central nervous system: Headache, laxative effect</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Endocrine &amp; metabolic: Hypercalcemia, hypophosphatemia, milk-alkali syndrome (with very high, chronic dosing and/or renal failure [headache, nausea, irritability, and weakness or alkalosis, hypercalcemia, renal impairment])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Gastrointestinal: Abdominal pain, anorexia, constipation, flatulence, hyperacidity (acid rebound), nausea, vomiting, xerostomia</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144381\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144366\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Gastrointestinal effects: Constipation, bloating, and gas are common with calcium supplements (especially carbonate salt) (IOM, 2011).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hypercalcemia: Chronic hypercalcemia may result in vascular calcification and other soft-tissue calcification (IOM, 2011).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Achlorhydria: Calcium absorption is impaired in achlorhydria; administration is followed by increased gastric acid secretion within 2 hours of administration especially with high doses. Common in the elderly, use an alternate salt (eg, citrate) and administer with food (IOM, 2011; Recker, 1985).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hypoparathyroid disease: Hypercalcemia and hypercalciuria are most likely to occur in hypoparathyroid patients receiving high doses of vitamin D.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Kidney stones (calcium-containing): Use caution when administering calcium supplements to patients with a history of kidney stones (IOM, 2011).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Renal insufficiency: Use with caution as these patients are more sensitive or susceptible to the effects of excess calcium (IOM, 2011).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Concurrent drug therapy issues: </i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Consult drug interactions database for more detailed information.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Vitamin D: It is recommended to concomitantly administer vitamin D for optimal calcium absorption when used for the treatment or prevention of conditions related to bone health (eg, osteoporosis).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Appropriate product selection: Multiple salt forms of calcium exist; close attention must be paid to the salt form when ordering and administering calcium; incorrect selection or substitution of one salt for another without proper dosage adjustment may result in serious over or under dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13298933\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144371\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=9185&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Acalabrutinib: Antacids may decrease the serum concentration of Acalabrutinib.  Management: Separate administration of acalabrutinib from the administration of any antacids by at least 2 hours in order to minimize the potential for a significant interaction.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Allopurinol: Antacids may decrease the absorption of Allopurinol. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Alpha-Lipoic Acid: Calcium Salts may decrease the absorption of Alpha-Lipoic Acid. Alpha-Lipoic Acid may decrease the absorption of Calcium Salts. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Amphetamines: Antacids may decrease the excretion of Amphetamines. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Antipsychotic Agents (Phenothiazines): Antacids may decrease the absorption of Antipsychotic Agents (Phenothiazines). <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Atazanavir: Antacids may decrease the absorption of Atazanavir. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Bictegravir: Antacids may decrease the serum concentration of Bictegravir.  Management: Bictegravir, emtricitabine, and tenofovir alafenamide can be administered while fasting at least 2 hours before antacids. Giving with or 2 hours after antacids is not recommended.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Bictegravir: Calcium Salts may decrease the serum concentration of Bictegravir.  Management: Bictegravir, emtricitabine, and tenofovir alafenamide can be administered with calcium salts under fed conditions, but coadministration with or 2 hours after a caclium salt is not recommended under fasting conditions.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Bisacodyl: Antacids may diminish the therapeutic effect of Bisacodyl. Antacids may cause the delayed-release bisacodyl tablets to release drug prior to reaching the large intestine.  Gastric irritation and/or cramps may occur. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Bismuth Subcitrate: Antacids may diminish the therapeutic effect of Bismuth Subcitrate.  Management: Avoid administration of antacids within 30 minutes of bismuth subcitrate (tripotassium bismuth dicitrate) administration.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Bisphosphonate Derivatives: Calcium Salts may decrease the serum concentration of Bisphosphonate Derivatives.  Management: Avoid administration of oral calcium supplements within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.<b> Exceptions: </b>Pamidronate; Zoledronic Acid.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Bisphosphonate Derivatives: Antacids may decrease the serum concentration of Bisphosphonate Derivatives.  Management: Avoid administration of antacids containing polyvalent cations within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.<b> Exceptions: </b>Pamidronate; Zoledronic Acid.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Bosutinib: Antacids may decrease the serum concentration of Bosutinib.  Management: Administer antacids more than 2 hours before or after bosutinib.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Bromperidol: Antacids may decrease the absorption of Bromperidol. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Calcium Acetate: Calcium Salts may enhance the adverse/toxic effect of Calcium Acetate. <i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Calcium Channel Blockers: Calcium Salts may diminish the therapeutic effect of Calcium Channel Blockers. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Calcium Polystyrene Sulfonate: Antacids may enhance the adverse/toxic effect of Calcium Polystyrene Sulfonate. The combined use of these two agents may result in metabolic alkalosis and/or loss of efficacy of the cation exchange resin.  Management: To minimize this interaction, consider: a)separating doses by 2 or more hours; b)rectal administration of the exchange resin; or c)alternatives to antacids. Monitor for metabolic alkalosis and attenuation of CPS effects. Avoid magnesium hydroxide.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Captopril: Antacids may decrease the serum concentration of Captopril. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cardiac Glycosides: Calcium Salts may enhance the arrhythmogenic effect of Cardiac Glycosides. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cefditoren: Antacids may decrease the serum concentration of Cefditoren.  Management: Concomitant use of cefditoren with antacids is not recommended. Consider alternative methods to control acid reflux (eg, diet modification) or alternative antimicrobial therapy. If antacid therapy can not be avoided, separate dosing by several hours.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cefpodoxime: Antacids may decrease the serum concentration of Cefpodoxime. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cefuroxime: Antacids may decrease the serum concentration of Cefuroxime.  Management: Administer cefuroxime axetil at least 1 hour before or 2 hours after the administration of short-acting antacids.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Chloroquine: Antacids may decrease the serum concentration of Chloroquine.  Management: Separate administration of antacids and chloroquine by at least 4 hours to minimize any potential negative impact of antacids on chloroquine bioavailability.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Corticosteroids (Oral): Antacids may decrease the bioavailability of Corticosteroids (Oral).  Management: Consider separating doses by 2 or more hours. Budesonide enteric coated tablets could dissolve prematurely if given with drugs that lower gastric acid, with unknown impact on budesonide therapeutic effects.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cysteamine (Systemic): Antacids may diminish the therapeutic effect of Cysteamine (Systemic). <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dabigatran Etexilate: Antacids may decrease the serum concentration of Dabigatran Etexilate.  Management: Dabigatran etexilate Canadian product labeling recommends avoiding concomitant use with antacids for 24 hours after surgery. In other situations, administer dabigatran etexilate 2 hours prior to antacids. Monitor clinical response to dabigatran therapy.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dabrafenib: Antacids may decrease the serum concentration of Dabrafenib. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dasatinib: Antacids may decrease the absorption of Dasatinib. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Deferiprone: Antacids may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Deferiprone: Calcium Salts may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Delavirdine: Antacids may decrease the serum concentration of Delavirdine.  Management: Separate doses of delavirdine and antacids by at least 1 hour. Monitor for decreased delavirdine therapeutic effects with this combination.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dexmethylphenidate: Antacids may increase the absorption of Dexmethylphenidate. Specifically, antacids may interfere with the normal release of drug from the extended-release capsules (Focalin XR brand), which could result in both increased absorption (early) and decreased delayed absorption. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Diacerein: Antacids may decrease the absorption of Diacerein. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">DOBUTamine: Calcium Salts may diminish the therapeutic effect of DOBUTamine. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dolutegravir: Calcium Salts may decrease the serum concentration of Dolutegravir.  Management: Administer dolutegravir at least 2 hours before or 6 hours after oral calcium. Administer dolutegravir/rilpivirine at least 4 hours before or 6 hours after oral calcium salts. Alternatively, dolutegravir and oral calcium can be taken together with food.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Eltrombopag: Calcium Salts may decrease the serum concentration of Eltrombopag.  Management: Administer eltrombopag at least 2 hours before or 4 hours after oral administration of any calcium-containing product.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Elvitegravir: Antacids may decrease the serum concentration of Elvitegravir.  Management: Separate administration of antacids and elvitegravir-containing products by at least 2 hours in order to minimize the risk for an interaction.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Erlotinib: Antacids may decrease the serum concentration of Erlotinib.  Management: Separate the administration of erlotinib and any antacid by several hours in order to minimize the risk of a significant interaction.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Estramustine: Calcium Salts may decrease the absorption of Estramustine. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Fosinopril: Antacids may decrease the serum concentration of Fosinopril.  Management: The US and Canadian fosinopril manufacturer labels recommend separating the doses of antacids and fosinopril by 2 hours.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gabapentin: Antacids may decrease the serum concentration of Gabapentin.  Management: Administer gabapentin at least 2 hours after antacid administration.  Monitor patients closely for evidence of reduced response to gabapentin therapy when both of these drugs are being used.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gefitinib: Antacids may decrease the serum concentration of Gefitinib.  Management: Administer gefitinib at least 6 hours before or after administration of an antacid, and closely monitor clinical response to gefitinib.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hyoscyamine: Antacids may decrease the serum concentration of Hyoscyamine.  Management: Administer immediate release hyoscyamine before meals and antacids after meals when these agents are given in combination.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Iron Salts: Antacids may decrease the absorption of Iron Salts. <b> Exceptions: </b>Ferric Carboxymaltose; Ferric Citrate; Ferric Gluconate; Ferric Hydroxide Polymaltose Complex; Ferric Pyrophosphate Citrate; Ferumoxytol; Iron Dextran Complex; Iron Isomaltoside; Iron Sucrose.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Itraconazole: Antacids may decrease the serum concentration of Itraconazole.  Management: Administer itraconazole at least 1 hour after and 2 hours before administration of any antacids.  Itraconazole oral suspension may be less sensitive to the effects of decreased gastric acidity.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ketoconazole (Systemic): Antacids may decrease the serum concentration of Ketoconazole (Systemic).  Management: Administer oral ketoconazole at least 2 hours prior to use of any antacid product.  Monitor patients closely for signs of inadequate clinical response to ketoconazole.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Lanthanum: Antacids may diminish the therapeutic effect of Lanthanum. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Ledipasvir: Antacids may decrease the serum concentration of Ledipasvir.  Management: Separate the administration of ledipasvir and antacids by 4 hours.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Mesalamine: Antacids may diminish the therapeutic effect of Mesalamine. Antacid-mediated increases in gastrointestinal pH may cause the premature release of mesalamine from specific sustained-release mesalamine products.  Management: Avoid concurrent administration of antacids with sustained-release mesalamine products.  Separating antacid and mesalamine administration, and/or using lower antacid doses may be adequate means of avoiding this interaction.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Methenamine: Antacids may diminish the therapeutic effect of Methenamine. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Methylphenidate: Antacids may increase the absorption of Methylphenidate. Specifically, antacids may interfere with the normal release of drug from the extended-release capsules (Ritalin LA brand), which could result in both increased absorption (early) and decreased delayed absorption. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Multivitamins/Fluoride (with ADE): May increase the serum concentration of Calcium Salts. Calcium Salts may decrease the serum concentration of Multivitamins/Fluoride (with ADE). More specifically, calcium salts may impair the absorption of fluoride. Management: Avoid eating or drinking dairy products or consuming vitamins or supplements with calcium salts one hour before or after of the administration of fluoride.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Multivitamins/Minerals (with ADEK, Folate, Iron): Antacids may decrease the serum concentration of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, antacids may decrease the absorption of orally administered iron.  Management: Separate dosing of oral iron-containing multivitamin preparations and antacids by as much time as possible in order to minimize impact on therapeutic efficacy of the iron preparation.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Mycophenolate: Antacids may decrease the absorption of Mycophenolate.  Management: Separate doses of mycophenolate and antacids by at least 2 hours. Monitor for reduced effects of mycophenolate if taken concomitant with antacids.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Neratinib: Antacids may decrease the serum concentration of Neratinib. Specifically, antacids may reduce neratinib absorption.  Management: Separate the administration of neratinib and antacids by giving neratinib at least 3 hours after the antacid.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Nilotinib: Antacids may decrease the serum concentration of Nilotinib.  Management: Separate the administration of nilotinib and any antacid by at least 2 hours whenever possible in order to minimize the risk of a significant interaction.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">PAZOPanib: Antacids may decrease the serum concentration of PAZOPanib.  Management: Avoid the use of antacids in combination with pazopanib whenever possible.  Separate doses by several hours if antacid treatment is considered necessary.  The impact of dose separation has not been investigated.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">PenicillAMINE: Antacids may decrease the serum concentration of PenicillAMINE. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Phosphate Supplements: Antacids may decrease the absorption of Phosphate Supplements.  Management: This applies only to oral phosphate administration.  Separating administer of oral phosphate supplements from antacid administration by as long as possible may minimize the interaction.<b> Exceptions: </b>Sodium Glycerophosphate Pentahydrate.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Phosphate Supplements: Calcium Salts may decrease the absorption of Phosphate Supplements.  Management: This applies only to oral phosphate and calcium administration. Administering oral phosphate supplements as far apart from the administration of an oral calcium salt as possible may be able to minimize the significance of the interaction.<b> Exceptions: </b>Sodium Glycerophosphate Pentahydrate.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Potassium Phosphate: Antacids may decrease the serum concentration of Potassium Phosphate.  Management: Consider separating administration of antacids and oral potassium phosphate by at least 2 hours to decrease risk of a significant interaction.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">QuiNIDine: Antacids may decrease the excretion of QuiNIDine. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Quinolones: Antacids may decrease the absorption of Quinolones. Of concern only with oral administration of quinolones.  Management: Avoid concurrent administration of quinolones and antacids to minimize the impact of this interaction. Recommendations for optimal dose separation vary by specific quinolone.<b> Exceptions: </b>LevoFLOXacin (Oral Inhalation).<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Quinolones: Calcium Salts may decrease the absorption of Quinolones. Of concern only with oral administration of both agents. <b> Exceptions: </b>LevoFLOXacin (Oral Inhalation); Moxifloxacin (Systemic).<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Raltegravir: Calcium Carbonate may decrease the serum concentration of Raltegravir. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rilpivirine: Antacids may decrease the serum concentration of Rilpivirine.  Management: Administer antacids at least 2 hours before or 4 hours after rilpivirine. Administer antacids at least 6 hours before or 4 hours after the rilpivirine/dolutegravir combination product.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Riociguat: Antacids may decrease the serum concentration of Riociguat.  Management: Separate the administration of antacids and riociguat by at least 1 hour in order to minimize any potential interaction.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rosuvastatin: Antacids may decrease the serum concentration of Rosuvastatin. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Sodium Polystyrene Sulfonate: Antacids may enhance the adverse/toxic effect of Sodium Polystyrene Sulfonate. The combined use of these two agents may result in metabolic alkalosis and/or loss of efficacy of the exchange resin.  Management: To minimize this interaction, consider: a)separating doses by 2 or more hours; b)rectal administration of the exchange resin; or c)alternatives to antacids. Monitor for metabolic alkalosis and attenuation of SPS effects. Avoid magnesium hydroxide.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Sotalol: Antacids may decrease the serum concentration of Sotalol.  Management: Avoid simultaneous administration of sotalol and antacids. Administer antacids 2 hours after sotalol.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Strontium Ranelate: Calcium Salts may decrease the serum concentration of Strontium Ranelate.  Management: Separate administration of strontium ranelate and oral calcium salts by at least 2 hours in order to minimize this interaction.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Sulpiride: Antacids may decrease the serum concentration of Sulpiride.  Management: Separate administration of antacids and sulpiride by at least 2 hours in order to minimize the impact of antacids on sulpiride absorption.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tetracyclines: Antacids may decrease the absorption of Tetracyclines.  Management: Separate administration of antacids and oral tetracycline derivatives by several hourse when possible to minimize the extent of this potential interaction.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tetracyclines: Calcium Salts may decrease the serum concentration of Tetracyclines.  Management: If coadministration of oral calcium with oral tetracyclines can not be avoided, consider separating administration of each agent by several hours.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Thiazide and Thiazide-Like Diuretics: May decrease the excretion of Calcium Salts. Continued concomitant use can also result in metabolic alkalosis.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Thyroid Products: Calcium Salts may diminish the therapeutic effect of Thyroid Products.  Management: Separate the doses of the thyroid product and the oral calcium supplement by at least 4 hours.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Trientine: Antacids may decrease the absorption of Trientine.  Management: Separate trientine dosing from other oral drugs (eg, antacids) by at least 1 hour. Monitor for decreased therapeutic effects of trientine if an antacid is initiated/dose increased, or increased effects if an antacid is discontinued/dose decreased.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Trientine: Calcium Salts may decrease the serum concentration of Trientine. Trientine may decrease the serum concentration of Calcium Salts. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Velpatasvir: Antacids may decrease the serum concentration of Velpatasvir.  Management: Separate administration of velpatasvir and antacids by at least 4 hours.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Vitamin D Analogs: Calcium Salts may enhance the adverse/toxic effect of Vitamin D Analogs. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144389\" class=\"block foi drugH1Div\"><span class=\"drugH1\">Food Interactions</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Food may increase calcium absorption. Calcium may decrease iron absorption. Bran, foods high in oxalates, or whole grain cereals may decrease calcium absorption. Management: Administer with food.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144384\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Calcium crosses the placenta. Intestinal absorption of calcium increases during pregnancy. The amount of calcium reaching the fetus is determined by maternal physiological changes. Calcium requirements are the same in pregnant and nonpregnant females (IOM, 2011). Calcium-based antacids are considered low risk during pregnancy; excessive use should be avoided (Mahadevan, 2006).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13333809\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Calcium is excreted in breast milk. The amount of calcium in breast milk is homeostatically regulated and not altered by maternal calcium intake. Calcium requirements are the same in lactating and nonlactating females (IOM 2011). Calcium-based antacids are probably compatible with breast-feeding (Mahadevan, 2006).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144385\" class=\"block dic drugH1Div\"><span class=\"drugH1\">Dietary Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Take with food. Limit intake of bran, foods high in oxalates, or whole grain cereals which may decrease calcium absorption.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Some products may contain phenylalanine and/or sodium.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dietary Reference Intake for Calcium (IOM 2011):</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">0 to &lt;6 months: Adequate intake: 200 mg <b>elemental calcium</b> daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">6 to 12 months: Adequate intake: 260 mg <b>elemental calcium</b> daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">1 to 3 years: RDA: 700 mg <b>elemental calcium</b> daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">4 to 8 years: RDA: 1,000 mg <b>elemental calcium</b> daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">9 to 18 years: RDA: 1,300 mg <b>elemental calcium</b> daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">19 to 50 years: RDA: 1,000 mg <b>elemental calcium</b> daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Females &ge;51 years: RDA: 1,200 mg <b>elemental calcium</b> daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Males: 51 to 70 years: RDA: 1,000 mg <b>elemental calcium</b> daily; &gt;70 years: RDA: 1,2000 mg<b> elemental calcium</b> daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pregnancy/Lactating: RDA: Requirements are the same as in nonpregnant or nonlactating females</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24764259\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Monitor plasma calcium levels if using calcium as an electrolyte supplement for deficiency or as treatment of hyperphosphatemia.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144377\" class=\"block rer drugH1Div\"><span class=\"drugH1\">Reference Range</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Serum calcium: 8.5 to 10.5 mg/dL (2.12 to 2.62 mmol/L) (IOM, 2011).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Due to a poor correlation between the serum ionized calcium (free) and total serum calcium, particularly in states of low albumin or acid/base imbalances, direct measurement of ionized calcium is recommended </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">In low albumin states, the corrected <b>total</b> serum calcium may be estimated by: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Corrected total calcium (mg/dL) = measured serum calcium (mg/mL) + 0.8 (4 - measured serum albumin [g/dL])</p>\n    <p style=\"text-indent:0em;margin-left:4em;text-align:justify;\">\n      <b>or </b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Corrected total calcium (mmol/L) = measured serum calcium (mmol/L) + 0.02 (40 - measured serum albumin [g/L])</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144365\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">As dietary supplement, used to prevent or treat negative calcium balance; in osteoporosis, it helps to prevent or decrease the rate of bone loss. Calcium is an integral component of the skeleton and also moderates nerve and muscle performance and allows normal cardiac function. Also used to treat hyperphosphatemia in patients with chronic kidney disease by combining with dietary phosphate to form insoluble calcium phosphate, which is excreted in feces. Calcium salts as antacids neutralize gastric acidity resulting in increased gastric and duodenal bulb pH; they additionally inhibit proteolytic activity of pepsin if the pH is increased &gt;4 and increase lower esophageal sphincter tone (IOM, 2011).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144380\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Minimal unless chronic, high doses; absorption predominantly in the duodenum and dependent on calcitriol and vitamin D; mean absorption of calcium intake varies with age (infants 60%, prepubertal children 28%, pubertal children 34%, adults 25%); during pregnancy, calcium absorption doubles; calcium is absorbed in soluble, ionized form; solubility of calcium is increased in an acid environment (IOM 2011); decreased absorption occurs in patients with achlorhydria, renal osteodystrophy, steatorrhea, or uremia </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: Primarily in bones, teeth (IOM, 2011)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Protein binding: ~40%, primarily to albumin (Wills 1971) </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Primarily feces (75%; as unabsorbed calcium); urine (22%) (IOM, 2011) </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2524390\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Capsules</b> (Florical Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">8.3-364 mg (100): $12.36</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Cal-Gest Antacid Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (150): $3.37</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Calci-Chew Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1250 (500 Ca) mg (100): $11.66</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Calcium Carbonate Antacid Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $1.00</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">750 mg (96): $1.67</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Maalox Childrens Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">400 mg (32): $4.19</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Maalox Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">600 mg (150): $4.56</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Titralac Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">420 mg (100): $4.54</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Tums Chewy Bites Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">750 mg (32): $4.70</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Tums Chewy Delights Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1177 mg (32): $4.70</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Tums E-X 750 Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">750 mg (96): $4.70</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Tums Extra Strength 750 Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">750 mg (8): $0.59</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Tums Freshers Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (25): $2.35</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Tums Kids Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">750 mg (36): $4.10</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Tums Lasting Effects Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (45): $3.96</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Tums Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (12): $0.59</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Tums Smoothies Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">750 mg (60): $4.70</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Tums Ultra 1000 Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1000 mg (72): $4.70</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Calcium Carbonate Antacid Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1250 mg/5 mL (473 mL): $12.19</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Cal-Carb Forte Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1250 (500 Ca) mg (100): $7.95</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Calcium Carbonate Antacid Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">648 mg (1000): $15.75</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Calcium Carbonate Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">600 mg (60): $9.99</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1250 (500 Ca) mg (100): $9.19</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1500 (600 Ca) mg (100): $10.95</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Caltrate 600 Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1500 (600 Ca) mg (150): $12.64</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Florical Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">8.3-364 mg (100): $11.39</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Oysco 500 Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (60): $4.35</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F144386\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Acical (BD);</li>\n      <li>Additiva Calcium (PL);</li>\n      <li>Andrews TUMS Antacid (AU);</li>\n      <li>Apo-Cal (HK, MY);</li>\n      <li>Bica (AR);</li>\n      <li>Biolectra (AT);</li>\n      <li>Bo-Ne-Ca (TH);</li>\n      <li>Bonacal (SG);</li>\n      <li>Boncal (BD);</li>\n      <li>Bonfit (LK);</li>\n      <li>Cal-Sup (AU);</li>\n      <li>Calbo (LK);</li>\n      <li>Calbone (PH);</li>\n      <li>Calcanate (TH);</li>\n      <li>Calcar (TH);</li>\n      <li>Calcefor (CL, PE);</li>\n      <li>Calci Aid (PH);</li>\n      <li>Calcichew (FI, GB, IE, LU, MT);</li>\n      <li>Calcifar (PL);</li>\n      <li>Calcigamma (DE);</li>\n      <li>Calcigran Sine (EE);</li>\n      <li>Calcilos (DE);</li>\n      <li>Calcimate (PH);</li>\n      <li>Calcinate (KW);</li>\n      <li>Calcioral (PT);</li>\n      <li>Calcit (BE, FR, IT, NL);</li>\n      <li>Calcium (BG, PL);</li>\n      <li>Calcium Carbonate (FR);</li>\n      <li>Calcium Dago (DE);</li>\n      <li>Calcium effervescens (PL);</li>\n      <li>Calcium Genericon (AT);</li>\n      <li>Calcium Klopfer (AT);</li>\n      <li>Calcium-Carbonat Salmon Pharma (CH);</li>\n      <li>Calcium-Phosphatbinder Bichsel (CH);</li>\n      <li>Calcium-Sandoz Forte (BG);</li>\n      <li>Calciumcarbonat Fresenius (CH);</li>\n      <li>Calciumcarbonat-Dial (AT);</li>\n      <li>Calcuren (FI);</li>\n      <li>Calnat (ID);</li>\n      <li>Calos (ID);</li>\n      <li>Calperos (CH, PL);</li>\n      <li>Calsan (CH, MX, PH);</li>\n      <li>Calsuba (ZA, ZW);</li>\n      <li>Calsum (TH);</li>\n      <li>Calsum Forte (TH);</li>\n      <li>Caltab (TH);</li>\n      <li>Caltess (PL);</li>\n      <li>Caltrate (AE, AU, BB, BH, BM, BS, BZ, CO, CY, EG, GY, IL, IQ, IR, JM, JO, KW, LB, LY, MX, MY, OM, PL, PR, QA, SA, SR, SY, TT, VN, YE);</li>\n      <li>Caltrate 600 (CO, CR, DO, GT, HN, NI, PA, PE, SV, VE);</li>\n      <li>Caltr&oacute;n (MX);</li>\n      <li>Cantacid (KR);</li>\n      <li>Caosina (ES);</li>\n      <li>Capool (TW);</li>\n      <li>CC-Nefro 500 (DE);</li>\n      <li>Chooz Antacid Gum 500 (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Cimascal (ES);</li>\n      <li>Cipcal (IN);</li>\n      <li>Dreisacarb (AT);</li>\n      <li>Edee (KR);</li>\n      <li>Fixateur phospho-calcique Bichsel (CH);</li>\n      <li>Fixical (FR);</li>\n      <li>FructiCal (PL);</li>\n      <li>Gastrocid (PH);</li>\n      <li>Iroviton Calcium (AT);</li>\n      <li>Isofem (EC);</li>\n      <li>Jasocal (LK);</li>\n      <li>Kal-Zarevet (IL);</li>\n      <li>Kalcidon (SE);</li>\n      <li>Kalcij-karbonat (HR);</li>\n      <li>Kalcijev karbonat (HR);</li>\n      <li>Kalcitena (SE);</li>\n      <li>Kalzonorm (AT);</li>\n      <li>Mastical (ES);</li>\n      <li>Maxi-calc (CH);</li>\n      <li>Maxi-Kalz (CZ);</li>\n      <li>Mubonet (MX);</li>\n      <li>N-Zarevet (IL);</li>\n      <li>Natecal (ES);</li>\n      <li>Noacid (UY);</li>\n      <li>Orocal (FR);</li>\n      <li>Os Cal (KW);</li>\n      <li>Oscal (NZ);</li>\n      <li>Osteocal 500 (FR, ID);</li>\n      <li>Osteomin (MX);</li>\n      <li>Pharcal (TH);</li>\n      <li>Pluscal (AR);</li>\n      <li>Plusssz balance calcium (PL);</li>\n      <li>Rowarolan (IE);</li>\n      <li>Tetesept Calcium (AT);</li>\n      <li>Titralac (NO);</li>\n      <li>Tums (IL);</li>\n      <li>Tums EX Sugar Free (IL);</li>\n      <li>Tums Smoothies EX Peppermint (IL);</li>\n      <li>Tums Ultra Assorted Berries (IL);</li>\n      <li>Tums Ultra Spearmint (IL);</li>\n      <li>Tzarevet X (IL);</li>\n      <li>Vicalvit (PL);</li>\n      <li>Vitacalcin (PL);</li>\n      <li>Weifa-Kalsium (NO)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Bauwens SF, Drinka PJ, Boh LE. Pathogenesis and management of primary osteoporosis. <i>Clin Pharm</i>, 1986;5:639-659.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/calcium-carbonate-drug-information/abstract-text/3527528/pubmed\" target=\"_blank\" id=\"3527528\">3527528</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Calci-Chew (calcium carbonate) [prescribing information]. Livonia, MN: Rugby Laboratories; June 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Calcium 600 (calcium carbonate) [prescribing information]. Livonia, MN: Rugby Laboratories; April 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Calcium carbonate [prescribing information]. Livonia, MN: Rugby Laboratories; May 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cal-Gest (calcium carbonate) [prescribing information]. Livonia, MN: Rugby Laboratories; May 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Eknoyan G, Levin A, Levin NW; National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. <i>Am J of Kidney Dis</i>. 2003:42 (4, suppl 3):S1-S201.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/calcium-carbonate-drug-information/abstract-text/14520607/pubmed\" target=\"_blank\" id=\"14520607\">14520607</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Heaney RP, Recker RR, Saville PD. Menopausal changes in calcium balance performance. <i>J Lab Clin Med</i>, 1978;92(6):953-63.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/calcium-carbonate-drug-information/abstract-text/739173/pubmed\" target=\"_blank\" id=\"739173\">739173</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    IOM (Institute of Medicine). <i>Dietary Reference Intakes for Calcium and Vitamin D</i>. Washington, DC: The National Academies Press; 2011.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mahadevan U, Kane S. American Gastroenterological Association Institute Medical Position Statement on the Use of Gastrointestinal Medications in Pregnancy,&quot; <i>Gastroenterology</i>. 2006;131(1):278-282.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/calcium-carbonate-drug-information/abstract-text/16831610/pubmed\" target=\"_blank\" id=\"16831610\">16831610</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Martin TJ, Kang Y, Robertson KM, et al. Ionization and Hemodynamic Effects of Calcium Chloride and Calcium Gluconate in the Absence of Hepatic Function. <i>Anesthesiology.</i> 1990; 73(1):62-65.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/calcium-carbonate-drug-information/abstract-text/2360741/pubmed\" target=\"_blank\" id=\"2360741\">2360741</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"19692157\"></a>Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GF. Benefits and harm of phosphate binders in CKD: a systematic review of randomized controlled trials. <i>Am J Kidney Dis</i>. 2009:54(4):619-637.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/calcium-carbonate-drug-information/abstract-text/19692157/pubmed\" target=\"_blank\" id=\"19692157\">19692157</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    NIH Consensus Conference. Optimal Calcium Intake. <i>JAMA</i>. 1994;272(24):1942-1948.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/calcium-carbonate-drug-information/abstract-text/7990248/pubmed\" target=\"_blank\" id=\"7990248\">7990248</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Recker RR. Calcium Absorption and Achlorhydria. <i>N Engl J Med</i>. 1985;313(2):70-73.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/calcium-carbonate-drug-information/abstract-text/4000241/pubmed\" target=\"_blank\" id=\"4000241\">4000241</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tums Chewy Delights (calcium carbonate) [prescribing information]. Philadelphia, PA: GlaxoSmithKline; date unknown.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tums Extra (calcium carbonate) [prescribing information]. Philadelphia, PA: GlaxoSmithKline; date unknown.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tums Freshers (calcium carbonate) [prescribing information]. Philadelphia, PA: GlaxoSmithKline; date unknown.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tums Kids (calcium carbonate) [prescribing information]. Philadelphia, PA: GlaxoSmithKline; date unknown.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tums Regular (calcium carbonate) [prescribing information]. Philadelphia, PA: GlaxoSmithKline; date unknown.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tums Smoothies (calcium carbonate) [prescribing information]. Philadelphia, PA: GlaxoSmithKline; date unknown.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tums Ultra (calcium carbonate) [prescribing information]. Philadelphia, PA: GlaxoSmithKline; date unknown.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wills MR and Lewin MR, &quot;Plasma Calcium Fractions and the Protein-Binding of Calcium in Normal Subjects and in Patients With Hypercalcaemia and Hypocalcaemia,&quot; <i>J Clin Pathol</i>, 1971, 24(9):856-66.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/calcium-carbonate-drug-information/abstract-text/5139991/pubmed\" target=\"_blank\" id=\"5139991\">5139991</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9185 Version 245.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F144392\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F144393\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F144430\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F144397\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F144415\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F144398\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F144399\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F24764257\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F45703130\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F144362\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms Considerations\" href=\"#F21879436\" class=\"outlineLink\">Dosage Forms Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F24764258\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F144378\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Use: Off-Label\" href=\"#F25475274\" class=\"outlineLink\">Use: Off-Label</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F144437\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F144369\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F144381\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F144366\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13298933\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F144371\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Food Interactions\" href=\"#F144389\" class=\"outlineLink\">Food Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F144384\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F13333809\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Dietary Considerations\" href=\"#F144385\" class=\"outlineLink\">Dietary Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F24764259\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Reference Range\" href=\"#F144377\" class=\"outlineLink\">Reference Range</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F144365\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F144380\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F2524390\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F144386\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9185|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=calcium-carbonate-patient-drug-information\" class=\"drug drug_patient\">Calcium carbonate: Patient drug information</a></li><li><a href=\"topic.htm?path=calcium-carbonate-pediatric-drug-information\" class=\"drug drug_pediatric\">Calcium carbonate: Pediatric drug information</a></li></ul></div></div>","javascript":null}